1. Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples. (20th March 2017) Authors: Caron, C.; Meley, R.; Le Cam Duchez, V.; Aillaud, M. F.; Lavenu‐Bombled, C.; Dutrillaux, F.; Flaujac, C.; Ryman, A.; Ternisien, C.; Lasne, D.; Galinat, H.; Pouplard, C. Journal: International journal of laboratory hematology Issue: Volume 39:Number 3(2017:Jun.) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is there a role for antiangiogenic therapy, bevacizumab, in the treatment of recurrent digestive bleeding due to angiodysplasia in Glanzmann's thrombasthenia?. (28th June 2016) Authors: Barré, A.; Dréanic, J.; Flaujac, C.; Roussel‐Robert, V.; Stieltjes, N.; Combe‐Marzelle, S.; Coriat, R.; Horellou, MH. Journal: Haemophilia Issue: Volume 22:Number 4(2016:Jul.) Page Start: e347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗